Strong results achieved in world-first Graphene enhanced cement roof tile trial
Highlights Production trial of graphene enhanced roof tiles with FP McCann achieves CO2 reduction of up to 14% Project conducted in the United Kingdom also showed 26% reduction in CEM I-to-concrete ratio required to produce concrete roof tiles...
Trial to test mild hyperbaric oxygen therapy during active treatment for aggressive brain cancer
LISMORE, Australia, March 16, 2026 /PRNewswire/ -- Australian researchers from Southern Cross University (SCU) and the Melbourne Integrative Oncology Group (MIOG) will launch a clinical study investigating whether hyperbaric oxygen therapy (HBOT)...
Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release
- Results Underscore Need for Continued Research and Diverse Treatment Pipeline CHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically...
First Graphene Limited Announces Cement & Concrete Segment Update
Highlights Production of 600 tonnes of low carbon PureGRAPH® enhanced cement to go ahead in December targeting several client applications Concrete roof tiles containing PureGRAPH® enhanced cement to be trialed by specialist precast concrete...